2 suspended. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Suspended 2 |
Follow AstraZeneca: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer Anastrozole, Anastrozole+Fulvestrant, Tamoxifen - Breast Cancer | Phase 2 | Suspended | The Netherlands Cancer Institute | 250 | 2008-07-01 | 2021-01-22 |
| Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV) ZD6126, Placebo - Carcinoma, Renal Cell, Kidney Neoplasms | Phase 2 | Suspended | AstraZeneca | 2003-08-01 | 2011-01-26 |
Breast Neoplasms (1) · Carcinoma, Renal Cell (1) · Kidney Neoplasms (1) · Neoplasm Metastasis (1)
Anastrozole (1) · N-acetylcochinol-O-phosphate (1) · Tamoxifen (1)
Netherlands (1) · United States (1)